Clinical Trial Update: Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of entecavir on regression and outcomes in patients with HBV-related liver fibrosis and cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Hepatitis B, Liver Cirrhosis | Phase 4 | Status: UNKNOWN